Primary Peptides, Inc.
PrivateLast Round
Series A
Feb 1, 2025
Est. Valuation
$75M
Total Funding Raised
$229,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Primary Peptides, Inc. is a biotechnology company that develops novel peptide therapeutics for neurological and cardiovascular diseases using protein manipulation technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Primary Peptides, Inc. Comparables
Compare Primary Peptides, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argenica Therapeutics | 83% | |
| Axoltis Pharma | 82% | |
| Infensa Bioscience | 79% |
Primary Peptides, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 1, 2025 | ||||
| Grant | May 1, 2023 | ||||
| Grant | May 2, 2022 |
Primary Peptides, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Research Council of Canada | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 413% MoM.
- May 15, 2026
Monthly visitors increased 435% MoM.
Primary Peptides, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Primary Peptides, Inc.'s valuation, stock price, and market status.
Is Primary Peptides, Inc. a public or private company?
Primary Peptides, Inc. is a private company.
What is the current stock price of Primary Peptides, Inc.?
Primary Peptides, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Primary Peptides, Inc. worth (valuation)?
Primary Peptides, Inc.'s valuation is estimated at $75.0M based on funding round data.
Can I buy Primary Peptides, Inc. stock?
Primary Peptides, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Primary Peptides, Inc.'s last funding round?
Primary Peptides, Inc.'s most recent funding round was Series A on February 1, 2025.
Who are the main investors in Primary Peptides, Inc.?
Key investors in Primary Peptides, Inc. include National Research Council of Canada.
Will Primary Peptides, Inc. IPO soon?
No public IPO plans have been announced for Primary Peptides, Inc..
How can I track Primary Peptides, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Primary Peptides, Inc.'s secondary market activity and sign up for updates.